Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esmolol for Myocardial Protection in HOCM Surgery
NCT05073094Phase 4Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Oct 2021
- Primary completion
- Jun 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of esmolol in Hypertrophic Obstructive Cardiomyopathy (HOCM), sponsored by E. Meshalkin National Medical Research Centre. Status: unknown.
02
Drugs
esmolol
03
Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Beyond the preview
Go deeper on NCT05073094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05073094.